Theriva Biologics, Inc.: Form 8-K, filed Jun 5, 2026
Filed with the SEC on Jun 5, 2026 and accepted by EDGAR at Jun 5, 2026, 20:05 ET.
Items reported
- Item 8.01 Other events
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-26-070966. Last ingested by Listed: Oct 24, 2026, 14:59 ET. Listed shows no prices and gives no investment advice.